Skip to content

EV / sales at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
0.7×-0.6×
Encompass Health Corporation logo
Encompass Health CorporationEHC
2.1×-0.3×
HCA Healthcare logo
HCA HealthcareHCA
+0.2×
National Healthcare logo
National HealthcareNHC
1.6×+0.5×
Astrana Health logo
Astrana HealthASTH
0.6×-0.2×
Universal Health Services logo
Universal Health ServicesUHS
0.9×-0.2×

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.9B-49.1%
Enterprise value$6.77B-16.0%
P/S0.6×-0.6×

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Calculated from Surgery Partners, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s EV / sales?
Surgery Partners, Inc. (SGRY) reported EV / sales of 1.9× in Q1 2026.
How has Surgery Partners, Inc.'s EV / sales changed year-over-year?
Surgery Partners, Inc.'s EV / sales decreased by 20.3% year-over-year, from 2.4× to 1.9×.
What is the long-term trend for Surgery Partners, Inc.'s EV / sales?
Over 5 years (2020 to 2025), Surgery Partners, Inc.'s EV / sales has grown at a -8.0% compound annual growth rate (CAGR), from 3.1× to 2.1×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.